Policresulen
QG51AD02 (WHO) | |
| Identifiers | |
|---|---|
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | (C9H8O4S)n |
| Molar mass | variable |
  (what is this?) (verify) | |
Policresulen is the polycondensation product of
canker sores. In some countries it is marketed under the trade name Albothyl or Polilen (Taiwan) or Faktu (combination with Cinchocaine
).
Medical uses
Policresulen is used in the treatment of gynecological infections since the 1950s.[3] The range of applications soon widened to include the therapy of other mucous membrane and skin lesions. The mechanism of action is twofold: next to its antiseptic effect, policresulen promotes the selective coagulation of necrotic and pathologically altered tissues while leaving healthy tissues intact.[1] The shedding of necrotic tissues is accompanied by the reepithelialization of the mucosal (or dermal) wound tissues.[1]
References
- ^ PMID 25932342.
- ^ "Policresulen". drugs.com.
- PMID 13235222.